Additional file 1 of Efficacy of chloroquine versus lopinavir/ritonavir in mild/general COVID-19 infection: a prospective, open-label, multicenter, randomized controlled clinical study
IntroductionTo effectively manage patients with coronavirus disease 2019 (COVID-19) while minimizing contact between medical staff, clinical trial protocol that facilitates contactless patient managem
Among consecutive patients with multidrug-resistant Pseudomonas aeruginosa bacteremia or pneumonia, we found those treated with ceftazidime-avibactam were more likely to develop resistance (defined as
ABSTRACT Introduction: Pro-inflammatory markers play a significant role in the disease severity of patients with COVID-19. Thus, anti-inflammatory therapies are attractive agents for potentially com
